LAVA Therapeutics N.V. (LVTX)
NASDAQ: LVTX · Real-Time Price · USD
1.659
-0.041 (-2.43%)
At close: Nov 14, 2025, 4:00 PM EST
1.650
-0.009 (-0.52%)
After-hours: Nov 14, 2025, 4:10 PM EST
LAVA Therapeutics Market Cap
LAVA Therapeutics has a market cap or net worth of $43.63 million as of November 14, 2025. Its market cap has decreased by -13.58% in one year.
Market Cap
43.63M
Enterprise Value
-6.65M
1-Year Change
-13.58%
Ranking
Category
Stock Price
$1.66
Market Cap Chart
Since the IPO on March 25, 2021, LAVA Therapeutics's market cap has decreased from $380.28M to $43.63M, a decrease of -88.53%. That is a compound annual growth rate of -37.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 43.40M | 73.55% |
| Dec 31, 2024 | 25.01M | -39.79% |
| Dec 29, 2023 | 41.54M | -54.86% |
| Dec 30, 2022 | 92.01M | -35.10% |
| Dec 31, 2021 | 141.77M | -62.72% |
| Mar 25, 2021 | 380.28M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 916.44B |
| Johnson & Johnson | 471.96B |
| AbbVie | 419.17B |
| UnitedHealth Group | 300.91B |
| AstraZeneca | 276.17B |
| Novartis AG | 256.16B |
| Merck & Co. | 232.23B |
| Abbott Laboratories | 224.84B |